Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1138 | 1021 | 1138 | 1067 | 1525 | 3233 |
Fund Return | 13.77% | 2.1% | 13.77% | 2.18% | 8.81% | 12.45% |
Place in category | 2316 | 2506 | 2316 | 1575 | 1157 | 99 |
% in Category | 80 | 83 | 80 | 65 | 65 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity Fund Feeder T EURe | 8.46B | 13.61 | 2.10 | 12.32 | ||
Fundsmith Equity Feeder Class R EUR | 8.46B | 13.04 | 1.60 | 11.78 | ||
Fundsmith Equity Feeder R EUR Inc | 8.46B | 13.04 | 1.61 | 11.76 | ||
Fundsmith Equity Fund Feeder I EURi | 8.46B | 13.77 | 2.26 | 12.49 | ||
Fundsmith Equity Fund Feeder T EURt | 8.46B | 13.61 | 2.11 | 12.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux N | 15.66B | 14.48 | 0.68 | - | ||
Cap Group New Perspective lux C EUR | 15.66B | 17.04 | 2.93 | - | ||
Cap Group NewPerspective lux ZL EUR | 15.66B | 16.33 | 2.33 | 10.85 | ||
Cap Group NewPerspective lux A7 EUR | 15.66B | 16.51 | 2.48 | - | ||
CapGroup NewPerspective lux ZLd EUR | 15.66B | 16.42 | 2.36 | 10.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.77 | 418.95 | -1.32% | |
Novo Nordisk B | DK0062498333 | 9.60 | 617.1 | -2.40% | |
Meta Platforms | US30303M1027 | 7.86 | 615.86 | +0.84% | |
L'Oreal | FR0000120321 | 5.96 | 327.40 | -1.36% | |
Stryker | US8636671013 | 5.40 | 365.66 | +0.43% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Neutral | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review